Mei Pharma, Inc.盘中异动大幅跳水5.31%报2.65美元

市场透视12-12

北京时间2024年12月12日00时43分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价急速下挫5.31%。截至发稿，该股报2.65美元/股，成交量952股，换手率0.01%，振幅3.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.01百万美元，每股收益-1.20美元，毛利-368000.00美元，市盈率-0.39倍。机构评级方面，在所有1家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490686721?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-12 00:43","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2490686721","market":"us","top_or_hot":-1,"title":"Mei Pharma, Inc.盘中异动 大幅跳水5.31%报2.65美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月12日00时43分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价急速下挫5.31%。截至发稿，该股报2.65美元/股，成交量952股，换手率0.01%，振幅3.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.01百万美元，每股收益-1.20美元，毛利-368000.00美元，市盈率-0.39倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mei Pharma, Inc.盘中异动 大幅跳水5.31%报2.65美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMei Pharma, Inc.盘中异动 大幅跳水5.31%报2.65美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 00:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月12日00时43分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价急速下挫5.31%。截至发稿，该股报2.65美元/股，成交量952股，换手率0.01%，振幅3.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.01百万美元，每股收益-1.20美元，毛利-368000.00美元，市盈率-0.39倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b","article_id":"2490686721","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212004321ab70099c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2490686721","pubTimestamp":1733935400,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月12日00时43分，Mei Pharma, Inc.股票出现异动，股价急速下挫5.31%。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Candel Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为443.35%、188.16%、103.39%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Candel Therapeutics, Inc.、Biora Therapeutics, Inc.，振幅分别为127.38%、104.12%、69.68%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CADL":"Candel Therapeutics, Inc.","BK4539":"次新股","MEIP":"MEI Pharma"},"translate_title":"Mei Pharma, Inc. plunged 5.31% to $2.65 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEIP":0.9,"CADL":0.82},"content_text":"北京时间2024年12月12日00时43分，Mei Pharma, Inc.（MEIP.us）股票出现异动，股价急速下挫5.31%。截至发稿，该股报2.65美元/股，成交量952股，换手率0.01%，振幅3.04%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.01百万美元，每股收益-1.20美元，毛利-368000.00美元，市盈率-0.39倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Mei Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Candel Therapeutics, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 (To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为443.35%、188.16%、103.39%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Candel Therapeutics, Inc.、Biora Therapeutics, Inc.，振幅分别为127.38%、104.12%、69.68%。Mei Pharma, Inc.公司简介：MEI Pharma Inc 专注于癌症新疗法的临床开发。 该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。 其临床开发产品组合还包括 Zandelisib，一种磷脂酰肌醇 3-激酶 delta 的口服抑制剂，用于治疗复发性慢性淋巴细胞白血病或滤泡性非霍奇金淋巴瘤患者； ME-344，一种基于异黄酮的线粒体抑制剂，用于治疗 HER2 阴性乳腺癌和 Pracinostat，一种口服组蛋白脱乙酰酶抑制剂。 在地理上，所有的商业活动都通过美国地区运作。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490686721"}

Mei Pharma, Inc.盘中异动 大幅跳水5.31%报2.65美元

精彩评论

Mei Pharma, Inc.盘中异动大幅跳水5.31%报2.65美元